Xilio Therapeutics, Inc. (XLO)
NASDAQ: XLO · Real-Time Price · USD
0.990
-0.040 (-3.88%)
Oct 29, 2024, 4:00 PM EDT - Market closed
Xilio Therapeutics Market Cap
Xilio Therapeutics has a market cap or net worth of $43.51 million as of October 29, 2024. Its market cap has decreased by -8.20% in one year.
Market Cap
43.51M
Enterprise Value
-22.75M
1-Year Change
-8.20%
Ranking
Category
Stock Price
$0.99
Market Cap Chart
Since the IPO on October 22, 2021, Xilio Therapeutics's market cap has decreased from $426.71M to $43.51M, a decrease of -89.80%. That is a compound annual growth rate of -53.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2024 | 43.50M | 188.08% |
| Dec 29, 2023 | 15.10M | -79.57% |
| Dec 30, 2022 | 73.90M | -83.19% |
| Dec 31, 2021 | 439.50M | 3.00% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Iterum Therapeutics | 42.69M |
| OKYO Pharma | 42.63M |
| NeueHealth | 42.15M |
| Apyx Medical | 41.92M |
| Equillium | 41.80M |
| Carisma Therapeutics | 41.54M |
| BioLineRx | 41.37M |
| Celularity | 40.89M |